-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Verastem, Lowers Price Target to $18

Benzinga·05/08/2026 12:10:26
Listen to the news
BTIG analyst Jeet Mukherjee maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $19 to $18.